Nonmotor symptom complex of Parkinson's disease - an under-recognized entity

Journal of Association of Physicians of India

Volumn 59, Issue 5, 2011, Pages

  Mehndiratta, Manmohan ^a   Garg, Rohit K ^a   Pandey, Sanjay ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NEUROPATHY; BEHAVIOR; CONSTIPATION; HUMAN; MENTAL DISEASE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; SENSORY DYSFUNCTION;

AUTONOMIC NERVOUS SYSTEM DISEASES; BEHAVIORAL SYMPTOMS; CONSTIPATION; HUMANS; MENTAL DISORDERS; PARKINSON DISEASE; SENSATION DISORDERS;

EID: 79956223454     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Przedborski S. Etiology and pathogenesis of Parkinson's disease. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2007;77-92.
2. Jankovic J, Shannon KM. Movement Disorders. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in clinical practice 5th ed. Philadelphia: Butterworth-Heinemann, Elsevier; 2008;2081-122
3. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5:525-35.
4. Mitra K, Gangopadhyaya PK, Das SK. Parkinsonism plus syndromes-A review. Neurology India 2003;5:183-8.
5. DeLong MR, Juncos JL. Parkinson's disease and other extrapyramidal movement disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., eds. Harrison's principles of internal medicine 17th ed. New York (NY): The McGraw-Hill Companies 2008;2549-59.
6. Behari M. Treatment of Parkinson's disease: fighting the surging enemy. Neurol India 1999;47:259-62.
7. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22:1901-11.
8. Ehringer H, Hornykiewicz O. Verteilung von noradranalin und dopamin (3-Hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems. Klin Wochershr 1960;38:1236-9.
9. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
10. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones 1817.
11. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12.
12. Hely MA, Morris JGL, Reid WGJ, Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005;20:190-9.
13. Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 2000;48:938-42.
14. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: time for a comprehensive assessment. Curr Neurol Neurosci Rep 2005;5:275-83.
15. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-7.
16. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Non motor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2008;23:101-6.
17. Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 2008;255:33-8.
18. Tolosa E, Compta Y, Gaig C. The premotor phase of Parkinson's disease. Parkinsonism Relat Disord 2007;13(Suppl):S2-7.
19. Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, et al. Identification of motor and non motor wearing off in Parkinson's disease:comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005;20:726-33.
20. Grosset D, Taurah L, Burn DJ, MacMahon D, Forbes A, Turner K, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 2007;78:465-9.
21. Chaudhuri KR, Martinez-Martin P, Schapira AHV et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest Study. Mov Disord 2006;21:916-23.
22. Ahlskog JE. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease. Mov Disord 2005;20:271-82.
23. Benarroch EE. Central neurotransmitters and neuromodulators in cardiovascular regulation. In: Mathias CJ, Bannister R, eds. Autonomic failure, 4th ed. Oxford, UK: Oxford University Press; 1999;37-44.
24. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-210.
25. Del Tredici K, Braak H. Idiopathic Parkinson's disease: staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C, eds. Molecular mechanisms in Parkinson's disease. Georgetown, TX: Landes Bioscience; 2004;1-32.
26. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002;58:341-6.
27. Saper C, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends in Neurosci 2001;24:726-31.
28. Diederich NJ, Goetz CG, Stebbins GT. Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model. Mov Disord 2005;20:130-40.
29. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64:1404-10.
30. Forno LS. Pathology of Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement Disorders, Neurology 2. London: Butterworths International Medical Reviews 1982:25-40.
31. Tandberg E, Larsen JP, Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998;13:895-9.
32. Poewe W. Nonmotor symptoms in Parkinson's disease. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders 5th ed. Philadelphia: Lippincott Williams and Wilkins 2007;67-76.
33. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38 % of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-93.
34. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331-9.
35. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: comparison with Parkinson's disease and controls. Brain 2000;123:1155-60.
36. Wolters and Braak J. Parkinson's disease: premotor clinicopathological correlations. Neural Trans 2006;70:309-19.
37. Abbott RD, Ross GW, White LR, Tanner CM, Nelson JS, Petrovicth H, et al. Excessive daytime sleepiness and the future risk of Parkinson's disease. Mov Disord 2005;20(10):S101(P 341).
38. Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov Disord 2001;16:500-06.
39. Ulivelli M, Rossi S, Lombardi C, et al. Polysomnographic characterisation of pergolide-induced sleep attacks in idiopathic PD. Neurology 2002;58:462-5.
40. Poewe W, Hogl B. Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease. Neurology 2004;63:12-6.
41. Marsh L. Neuropsychiatric aspects of Parkinson's disease. Psychosomatics 2000;41:15-23.
42. Starkstein SE, Mayberg HS. Depression in Parkinson's disease, In: Starkstein SE, Robinson RG eds. Depression in neurologic disease. Baltimore, MD: Johns Hopkins University Press 1993;97-116.
43. Mayeux R. The mental state in Parkinson's disease. In: Koller WC, ed. Handbook of Parkinson's disease, 2nd ed. New York (NY): Marcel Dekker 1992;159-84.
44. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-54.
45. Schiffer RB, Kurlan R, Rubin A. Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988;145:1020-2.
46. Hanagasi HA, Emre M. Management of the neuropsychiatric and cognitive symptoms in Parkinson's disease. Practical Neurology 2002;2:94-102.
47. Veazey C, Aki SOE, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson's Disease. J Neuropsychiatry Clin Neurosci 2005;17:310-23.
48. Fukunishi I, Hosokawa K, Ozaki S. Depression antedating the onset of Parkinson's disease. Jpn J Psychiatry Neurol 1991;45:7-11.
49. Huber S, Paulson GW, Shuttleworth EC. Depression in Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:47-51.
50. Holroyd S, Currie LJ, Wooten GF. Depression is associated with impairment of ADL, not motor function in Parkinson disease. Neurology 2005;64:2134-5.
51. Richard IH, Schiffer RB, Kurlan R. Anxiety and Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:383-92.
52. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990;147:217-20.
53. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D. "Panic attacks" in Parkinson's disease: a long-term complication of levodopa therapy. Acta Neurol Scand 1993;87:14-8.
54. Berrios GE, Campbell C, Politynska BE. Autonomic failure, depression and anxiety in Parkinson's disease. Br J Psychiatry 1995;166:789-92.
55. Iruela LM, Ibanez-Rojo V, Palanca I, et al. Anxiety disorders and Parkinson's disease. Am J Psychiatry 1992;149:719-20.
56. Cash R, Dennis T, L'Heureux R, et al. Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus. Neurology 1987;37:42-6.
57. Lauterbach EC. The locus ceruleus and anxiety disorders in demented and nondemented familial parkinsonism (letter). Am J Psychiatry 1993;150:994.
58. Lauterbach EC, Duvoisin RC. Anxiety disorders in familial parkinsonism (letter). Am J Psychiatry 1992;148:274.
59. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-9.
60. Wolters EC. Dopaminomimetic psychosis in Parkinson's disease patients. Neurology 1999;52(suppl 3):S10-S13.
61. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology. Neurology 1998;50(suppl 3):S1-S57.
62. Peyser CE, Naimark D, Zuniga R, et al. Psychoses in Parkinson's disease. Semin Clin Neuropsychiatry 1998;3:41-50.
63. Aarsland D, Larsen JP, Cummings JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson's disease: a community-based study. Arch Neurol 1999;56:595-601.
64. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-37.
65. Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004;61:1906-11.
66. Cummings J. Reconsidering diagnostic criteria for dementia with Lewy bodies: highlights from the third international workshop on dementia with Lewy bodies and Parkinson's disease dementia, Sep 17-20, 2003, Newcastle upon Tyne, UK. Rev Neurol Dis 2004;1:31-4.
67. Li YJ, Hauser MA, Scott WK, et al. Apolipoprotein E controls the risk and age at onset of Parkinson's disease. Neurology 2004;62:2005-09.
68. Mohr E, Mendis T, Grimes JD. Late cognitive changes in Parkinson's disease with an emphasis on dementia. Adv Neurol 1995;65:97-113.
69. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology 1986;36:73-5.
70. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 2005;15:76-82.
71. Bannister R, Mathias CJ. Clinical features and evaluation of primary chronic autonomic failure syndromes. In: Mathias CJ, Bannister R, eds. Autonomic failure, 4th edn. Oxford, UK: Oxford University Press, 1999;307-16.
72. Magalhaes M, Wenning GK, Daniel SE, Quinn NP. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease: a retrospective comparison. Acta Neurol Scand 1995;91:98-102.
73. Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hyotension in Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:584-9.
74. Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123-I] MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-5.
75. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990;53:463-8.
76. Jost WH. Gastrointestinal motility problems in patients with Parkinson's disease: effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 1997;10:249-58.
77. Den Hartog Jager WA, Bethlem J. the distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 1960;23:283-90.
78. Okun M, Walter BL, McDonald WM, et al. Beneficial effects of testosterone replacement for the non motor symptoms of Parkinson's disease. Arch Neurol 2002;59:1750-3.
79. Yu M, Roane DM, Miner CR, Fleming F, Rogers JD. Dimensions of sexual dysfunction in Parkinson Disease. Am J Geriatr Psychiatry 2004;12:221-6.
80. Tyvaert L, Devos D, Rigot JM, Blond S, Reyns N, Destee A. Sexual dysfunction and sub-thalamic stimulation in Parkinson's disease. Park Related Disord 2005;11:116(PT003-17).
81. Pezzella FR, Colosimo C, Vanacore N, et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord 2005;20:77-81.
82. Fowler CJ. Investigation and treatment of bladder and sexual dysfunction in diseases affecting the autonomic nervous system. In: Mathias CJ, Bannister SR, eds. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. London: Oxford; 1999;30:296-303.
83. Charcot JM. Lectures on diseases of the nervous system. Singerson S, trans. London: The New Syndenham Society 1877;1:137.
84. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986;1:45-9.
85. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology 2002;13:408-13.
86. Quinn NP, Koller WC, Lang AE, et al. Painful Parkinson's disease. Lancet 1996;1:1366-9.
87. Schott GD. Pain in Parkinson's disease. Pain 1985;22:407-11.
88. Buzas B, Max MB. Pain in Parkinson's disease. Neurology 2004;62:2156-67.
89. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis 1975;28:493-7.
90. Siderowf A, Jdennings D, Connolly J, Doty R, Mareck K, Stern M. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Mov Disord 2007;22:2249-55.
91. Ross W, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk of future Parkinson's disease. Mov Disord 2005;20:P439 (Abstract).